{"id":13519,"date":"2011-01-03T09:30:00","date_gmt":"2011-01-03T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/marvecspharma-uno-scandaloso-silenzio\/"},"modified":"2011-01-03T09:30:00","modified_gmt":"2011-01-03T08:30:00","slug":"marvecspharma-uno-scandaloso-silenzio","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/marvecspharma-uno-scandaloso-silenzio\/","title":{"rendered":"Marvecspharma, a scandalous silence"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\" align=\"center\"><strong><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\" align=\"center\"><strong><img loading=\"lazy\" decoding=\"async\" style=\"width: 812px; height: 222px\" height=\"138\" width=\"400\" alt=\"\" src=\"\/FCKUserFile\/FCKUserFilesNaz\/N2825.jpg\" \/><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><strong><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">Ai lavoratori Marvecspharma,<\/span><\/strong><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">In data odierna, le scriventi OO.SS. sono state convocate insieme all&#8217;esecutivo R.S.U. dalla Direzione Aziendale per comunicazioni urgenti riguardanti la cessazione dei rapporti con la Societ&agrave; Bioprojet in relazione al contratto della specialit&agrave; Tiorfix.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">In rappresentanza dell&rsquo;Azienda erano presenti il Sig. Mario Ferraro, la Dott,ssa Silvia Pellegrino ed il Dott. Alessandro Magliano.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: normal; text-align: justify\"><strong><span style=\"font-size: 10pt; color: #333333; font-family: 'Georgia','serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">In detta riunione ci &egrave; stato comunicato che a far data dal 03 gennaio 2011 l&#8217;Azienda Marvecspharma non sar&agrave; pi&ugrave; in grado di far svolgere alc<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; Ai lavoratori Marvecspharma, &nbsp; In data odierna, le scriventi OO.SS. sono state convocate insieme all&#8217;esecutivo R.S.U. dalla Direzione Aziendale per comunicazioni urgenti riguardanti la cessazione dei rapporti con la Societ&agrave; Bioprojet in relazione al contratto della specialit&agrave; Tiorfix. &nbsp; In rappresentanza dell&rsquo;Azienda erano presenti il Sig. Mario Ferraro, la Dott,ssa Silvia Pellegrino &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13519","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13519"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13519\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}